<- Back to digest

JSES - 2026-11-04 - Journal Article

Rotator Cuff Repair with Concomitant Biceps Tenodesis is Cost-Effective at Mid-Term Follow-up: A Systematic Review and Cost-Effective Analysis.

Berreta RS, Badin D, Koyejo LD, Chan D, Ashkar A, Siragusa J, Harris E, Fox H, Jain A, Srikumaran U

cost-effectivenessLOE IIIn = N/A (decision tree model; inputs derived from literature)5-year time horizon (modeled)

Topics

shoulder elbowsports
PMID: 42982320DOI: 10.1016/j.jse.2026.10.028View on PubMed ->

Key Takeaway

RCR with concomitant biceps tenodesis yields an ICER of $13,064/QALY over 5 years, well below the $50,000/QALY willingness-to-pay threshold, making it cost-effective in 88.51% of 1,000 Monte Carlo simulations.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This decision tree cost-utility analysis compared RCR alone versus RCR with biceps tenodesis over a 5-year horizon using EQ-5D-derived QALYs, literature-sourced transition probabilities, and a $50,000/QALY WTP threshold. RCR with BT generated 3.713 QALYs at $34,182 versus 3.651 QALYs at $33,372 for RCR alone, yielding an ICER of $13,064/QALY and a positive net monetary benefit of $2,289. Cost-effectiveness was robust to tenodesis implant costs up to $3,048, revision rates up to 6.7%, and additional operative time up to 53.7 minutes on sensitivity analysis.

Key Limitation

The model relies entirely on literature-derived utility and transition probability inputs rather than individual patient-level data, making it susceptible to garbage-in/garbage-out bias if source study populations are heterogeneous.

Original Abstract

BACKGROUND

There is limited evidence describing the cost-effectiveness of isolated rotator cuff repair (RCR) compared to rotator cuff repair with biceps tenodesis (BT) in the treatment of primary rotator cuff tears at mid-term follow-up.

PURPOSE

(1) To perform a cost utility analysis comparing RCR to RCR with BT in patients with rotator cuff tears over a 5-year time horizon.

METHODS

A decision tree economic model was constructed to evaluate the cost-effectiveness of RCR vs RCR with BT across a 5-year time horizon. Model transition probabilities, costs, and health utility measures, based on EQ-5D (European Quality of Life-5 Dimension) scores, were derived from the literature. Health utility was measured in quality-adjusted life years (QALYs) and cost-effectiveness was based on the incremental cost-effectiveness ratio (ICER) considering a willingness to pay (WTP) threshold of $50,000/QALY. Monte Carlo probabilistic and one-way sensitivity analysis was performed to assess for parameter uncertainty. Each cycle length was defined as 1 year, and 5-year costs and utilities were calculated with 3% annual discounting.

RESULTS

Over a 5-year horizon, RCR with BT yielded 3.713 QALYs at a mean cost of $34,182 compared to 3.651 QALYs and $33,372 for RCR alone. RCR with BT was found to be cost-effective with an ICER of $13,064/QALY and a positive net monetary benefit of $2,289. RCR with BT was the preferred treatment in 88.51% of 1,000 simulations on probabilistic sensitivity analysis. One-way sensitivity analyses demonstrated cost-effectiveness for performing RCR with BT was maintained with tenodesis implant costs up to $3,048, revision rates up to 6.7%, and additional operative time up to 53.7 minutes.

CONCLUSION

Despite higher upfront costs, performing biceps tenodesis at the time of index rotator cuff repair provides greater quality-adjusted life years and is cost-effective compared to isolated rotator cuff repair at mid-term follow-up.

LEVEL OF EVIDENCE

Level III, Economic Study.